New study sheds light on impact of fluvoxamin : vimarsana.co

<p>Prior to this study, the impact of a high dosage of fluvoxamine on symptom duration for mild to moderate cases of COVID-19 had been uncertain.&nbsp;</p>

Related Keywords

United States , American , Ahmad Mourad , Paulina Rebolledo , Thomas Stewart , University Of Virginia School Data Science , Study Group , American Medical Association , Emory University , School Of Data Science , Duke University , Data Science , American Medical , Dose Fluvoxamine , Sustained Recovery , Outpatients With ,